BRIEF published on 10/17/2025 at 10:00, 1 month 18 days ago Ossiam US Minimum Variance ESG NR UCITS ETF to Close Net Asset Value Redemption Process Shareholder Advisory Closure Notice ETF Delisting
BRIEF published on 10/17/2025 at 10:00, 1 month 18 days ago Clôture de l'ETF Ossiam US Minimum Variance ESG NR UCITS Avis Aux Actionnaires Valeur Nette D'inventaire Processus De Rachat Avis De Fermeture Retrait De La Cote Des ETF
PRESS RELEASE published on 10/17/2025 at 09:55, 1 month 18 days ago OSSIAM US MINIMUM VARIANCE ESG NR UCITS ETF: Notice of closure Ossiam IRL ICAV announces closure of various UCITS ETFs due to economic viability concerns. Shareholders notified of compulsory redemption. Funds to be managed until Closure Date Compulsory Redemption Economic Viability Closure UCITS ETFs Ossiam IRL ICAV
PRESS RELEASE published on 03/17/2023 at 11:25, 2 years 8 months ago OSSIAM US MINIMUM VARIANCE ESG NR UCITS ETF: Delisting from Euronext Paris
Published on 12/05/2025 at 02:35, 5 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 7 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 36 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 41 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 52 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 7 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 22 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
